Clinical Trial Results: Dilatrend [carvedilol]

Product Name: Dilatrend [carvedilol]
Date of Report: 12/19/2003
Phase: III
A multicenter randomized double-blind, controlled study to compare the effect on mortality and morbidity over 46–74 months of carvedilol (Dilatrend) (oral titrated administration of 6.25 mg bid to 25 mg bid, with a preceding dose of 3.125 mg bid) and metoprolol (oral titrated administration of 12.5 mg bid to 50 mg bid with a preceding dose of 5 mg bid) in patients with chronic heart failure (NYHA II-IV).

Product Name: Dilatrend [carvedilol]
Date of Report: To be Published
Phase: IV
CALL study. A Study of the Influence of Dilatrend (Carvedilol) on Physical Fitness and Quality of Life in Patients With Heart Failure

Product Name: Dilatrend [carvedilol]
Date of Report: 3/23/2006
Phase: IV
Tolerability of Carvedilol Therapy in Elderly Patients with Congestive Heart Failure: The COLA II Study

Product Name: Dilatrend [carvedilol]
Date of Report: 4/1/2006
Phase: III
An open label, randomized, active controlled, multicentre study to assess efficacy and safety of carvedilol versus metoprolol in patients with chronic stable angina pectoris.